Paying a toll for acute lung allograft rejection

American Journal of Respiratory and Critical Care Medicine

Volumn 168, Issue 6 I, 2003, Pages 623-624

  Belperio, John A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; TOLL LIKE RECEPTOR 4;

ACUTE DISEASE; ALLOGRAFT; AUTOIMMUNITY; BRONCHIOLITIS; BRONCHOSCOPY; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; EPITHELIUM CELL; EVALUATION; FOLLOW UP; GENETIC POLYMORPHISM; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; LUNG BIOPSY; LUNG TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; RISK FACTOR;

ACUTE DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HUMANS; IMMUNITY, NATURAL; LUNG TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOLL-LIKE RECEPTORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0141729472     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2306023     Document Type: Editorial

References (16)

1. Kaisho T, Akira S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 2002;1589:1-13.
2. Sabroe I, Parker LC, Wilson AG, Whyte MK, Dower SK. Toll-like receptors: their role in allergy and non-allergic inflammatory disease. Clin Exp Allergy 2002;32:984-989.
3. Strieter RM. Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002;109:699-705.
4. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997;155:789-818.
5. Kelly K, Hertz MI. Obliterative bronchiolitis. Clin Chest Med 1997;18:319-338.
6. Trulock EP. Management of lung transplant rejection. Chest 1993;103:1566-1576.
7. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081-1091.
8. Paradis I, Yousem S, Griffith B. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med 1993;14:751-763.
9. Sharpies LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002;21:271-281.
10. Husain AN, Siddiqui MT, Holmes EW, Chandrasekhar AJ, McCabe M, Radvany R, Garrity ER. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999;159:829-833.
11. Palmer SM, Burch LH, Davis RD, Herczyk WF, Howell DN, Reinsmoen NL, Schwartz DA. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003;168:628-632.
12. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-191.
13. Goldstein DR, Tesar BM, Akira S, Lakkis FG. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003;111:1571-1578.
14. Kleeberger W, Versmold A, Rothamel T, Glockner S, Bredt M, Haverich A, Lehmann U, Kreipe H. Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol 2003;162:1487-1494.
15. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002;186:1522-1525.
16. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-192.